1887

Abstract

In-vitro proteinase production by oral isolates from patients with and without HIV infection (18 isolates from each group) was assessed by image analysis of a plate assay, with bovine serum albumin (BSA) as a substrate. The effect of sub-minimal inhibitory concentrations (sub-MICs) of nystatin, amphotericin B, clotrimazole and miconazole on in-vitro proteinase production by these yeast isolates was also investigated. Proteinase production by isolates from patients with HIV infection was significantly greater than production by those from individuals without infection. All 18 isolates from HIV-infected individuals produced proteinase, in comparison to 56% of isolates from uninfected individuals. Pre-exposure of isolates (seven proteinase producers from each group) to 1/4 and 1/16 MICs of nystatin, amphotericin B, clotrimazole and miconazole resulted in decreased proteinase production in all isolates tested. However, after exposure to the four antimycotic agents, proteinase production was decreased to a significantly greater extent in isolates from uninfected individuals than in those with HIV disease. Furthermore, when the relative concentration effect of antimycotic agents on proteinase production was compared, isolates from the HIV-free group demonstrated a salient dose-response relationship compared with the HIV-infected group. These results indicate that from patients with HIV infection are significantly more proteolytic than those from individuals without the infection, and that polyenes and imidazoles curtail the proteolytic activity of all isolates, albeit to a lesser extent in those from HIV-infected patients. It appears that HIV disease favours oral colonisation by more proteolytic isolates, with resilient proteolytic activity.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-44-4-311
1996-04-01
2024-12-10
Loading full text...

Full text loading...

/deliver/fulltext/jmm/44/4/medmicro-44-4-311.html?itemId=/content/journal/jmm/10.1099/00222615-44-4-311&mimeType=html&fmt=ahah

References

  1. Macdonald F., Odds F. C. Virulence for mice of a proteinase secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol 1983; 29:431–438
    [Google Scholar]
  2. Rüchel R. Properties of a purified proteinase from the yeast Candida albicans. Biochem Biophys Acta 1981; 659:99–113
    [Google Scholar]
  3. Kwong-Chung K. J., Lehman D., Good C., Magee P. T. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun 1985; 49:571–575
    [Google Scholar]
  4. Rüchel R., Tegeler R., Trost M. A comparison of secretory proteinases from different strains of Candida albicans. Sabouraudia 1982; 20:233–244
    [Google Scholar]
  5. Kaminishi H., Miyaguchi H., Tamaki T. Degradation of humoral host defense by Candida albicans proteinase. Infect Immun 1995; 63:984–988
    [Google Scholar]
  6. Negi M., Tsuboi R., Matsui T., Ogawa H. Isolation and characterization of proteinase from Candida albicans: substrate specificity. J Invest Dermatol 1984; 83:32–36
    [Google Scholar]
  7. Hattori M., Yoshiura K., Negi M., Ogawa H. Keratinolytic proteinase produced by Candida albicans. Sabouraudia 1984; 22:175–183
    [Google Scholar]
  8. Macdonald F., Odds F. C. Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J Med Microbiol 1980; 13:423–435
    [Google Scholar]
  9. Rüchel R. A variety of Candida proteinases and their possible targets of proteolytic attack in the host. Zentralbl Backteriol Mikrobiol Hyg [A] 1984; 257:266–274
    [Google Scholar]
  10. Datta A., Ganesan K., Natarajan K. Current trends in Candida albicans research. Adv Microbiol Physiol 1989; 30:53–88
    [Google Scholar]
  11. Staib F. Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia 1965; 4:187–193
    [Google Scholar]
  12. Rüchel R. Virulence factors of Candida species. In Samar-anayake L. P., MacFarlane T. W. (eds) Oral candidosis London: Wright-Butterworth; 199047–65
    [Google Scholar]
  13. Samaranayake L. P. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol 1992; 73:171–180
    [Google Scholar]
  14. Holmstrup P., Samaranayake L. P. Acute and AIDS-related oral candidoses. In Samaranayake L. P., MacFarlane T. W. (eds) Oral candidosis London: Wright-Butterworth; 1990133–155
    [Google Scholar]
  15. De Bemardis F., Boccanera M., Rainaldi L., Guerra C. E., Quinti L., Cassone A. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. Eur J Epidemiol 1992; 8:362–367
    [Google Scholar]
  16. McCullough M., Ross B., Reade P. C. Oral Candida albicans from patients infected with the human immunodeficiency virus and characterization of a genetically distinct subgroup of Candida albicans. Austr Dent J 1995; 40:91–97
    [Google Scholar]
  17. Angiolella L., De Bemardis F., Bromuro C., Modello F., Ceddia T., Cassone A. The effect of antimycotics on secretory acid proteinase of Candida albicans. J Chemother 1990; 2:55–61
    [Google Scholar]
  18. McGinnis M. G., Rinaldi M. G. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids. In Lorian V. (ed) Antibiotics in laboratory medicine 3rd edn Baltimore: Williams and Wilkins; 1991198–278
    [Google Scholar]
  19. Challacombe S. J. Immunologic aspects of oral candidiasis. Oral Surg Oral Med Oral Pathol 1994; 78:202–210
    [Google Scholar]
  20. Germaine G. R., Tellefson L. M., Johnson G. L. Proteolytic activity of Candida albicans: action on human salivary proteins. Infect Immun 1978; 22:861–866
    [Google Scholar]
  21. Samaranayake L. P., Hughes A., MacFarlane T. W. The proteolytic potential of Candida albicans in human saliva supplemented with glucose. J Med Microbiol 1984; 17:13–22
    [Google Scholar]
  22. Samaranayake Y. H., MacFarlane T. W., Samaranayake L. P., Aitchison T. The in vitro proteolytic and saccharolytic activity of Candida species in human saliva. Oral Microbiol Immunol 1994; 9:229–235
    [Google Scholar]
  23. Mason D. K., Chisholm D. M. Salivary glands in health and disease. London: W B Saunders; 1975410
    [Google Scholar]
  24. Atkinson J. C., Yeh C. K., Bermudez D., Fox P. C., Baum B. J. Longitudinal evaluation of major salivary gland function in HIV-1 infected patients. J Oral Pathol Med 1989; 18:469–470
    [Google Scholar]
  25. Atkinson J. C., Yeh C. K., Oppenheim F. G., Bermudez D., Baum B. J., Fox P. C. Evaluation of salivary antimicrobial proteins following HIV-1 infection. Acquir Immune Defic Syndr 1990; 3:41–48
    [Google Scholar]
  26. Mandel I. D., Barr C. E., Turgeon L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 1992; 21:209–213
    [Google Scholar]
  27. Marder M. Z., Barr C. E., Mandel I. D. Cytomegalovirus presence and salivary composition in acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1985; 60:372–376
    [Google Scholar]
  28. Ogrydziak D. M. Yeast extracellular proteases. Crit Revi Biotechnol 1993; 13:1–55
    [Google Scholar]
  29. Samaranayake L. P. Superficial fungal infections. In Scully C. (ed) Current opinions in Dentistry Philadelphia: Current Science; 1991415–122
    [Google Scholar]
/content/journal/jmm/10.1099/00222615-44-4-311
Loading
/content/journal/jmm/10.1099/00222615-44-4-311
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error